Senate Finance chair goes after Amgen again on US taxes, asking for payment specifics

Senate Finance Chair Ron Wyden is asking Amgen again for more information on its financials as he continues to dig into the way pharma companies use subsidiaries in low- or zero-tax countries to lower their bills.